KindlyMD (NASDAQ:NAKA) Sees Strong Trading Volume - Here's What Happened

Key Points

• KindlyMD saw a significant increase in trading volume with over 6.7 million shares traded, marking a 115% rise from the previous session.
• Analysts from Maxim Group initiated coverage with a buy rating and a target price of $8.00, while the stock is currently trading at $2.99.
• The company reported a negative earnings per share of ($0.34) and has a market capitalization of $1.15 billion.

Shares of KindlyMD, Inc. (NASDAQ:NAKA - Get Free Report) saw an uptick in trading volume on Friday . 6,712,221 shares were traded during mid-day trading, an increase of 115% from the previous session's volume of 3,118,135 shares.The stock last traded at $2.99 and had previously closed at $3.95.

Analyst Ratings Changes

Separately, Maxim Group began coverage on KindlyMD in a research note on Wednesday, September 3rd. They issued a "buy" rating and a $8.00 price target for the company. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat, the company presently has an average rating of "Buy" and an average target price of $8.00.

KindlyMD Trading Down 22.3%

The stock has a 50-day moving average of $9.35. The stock has a market capitalization of $1.15 billion, a PE ratio of -3.57 and a beta of 33.96.

KindlyMD (NASDAQ:NAKA - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported ($0.34) earnings per share for the quarter. KindlyMD had a negative return on equity of 131.09% and a negative net margin of 244.00%.The firm had revenue of $0.41 million for the quarter.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.